SONA

SONA operates at the intersection of neurotechnology, wearable devices, digital health, and consumer wellness. Its product proposition combines vagus nerve stimulation with biometric tracking and software-based protocol personalization, rather than presenting stimulation as a fixed, one-size-fits-all routine. The system is described as using heart-rate variability and respiration signals to adapt protocols, with audio and breath pairing, stress coaching, and analytics available through its companion app. This places the offering in a consumer-oriented category that overlaps with stress-management wearables and digital wellness tools, while its stimulation hardware gives it a distinct neurotechnology component. Its stated differentiators are the closed-loop approach, integrated hardware and app, short daily sessions, and core app access without a required monthly subscription.

The stated use cases include stress recovery, sleep, focus, and nervous-system regulation. The company also describes AI stress coaching, analytics, wearable integrations, and custom protocol creation, suggesting a product design that extends beyond a standalone stimulation device. No employee changes or recent layoffs are indicated, but there is also no hiring news. Consequently, the product description suggests an effort to build an adaptive, ongoing user experience, while the company's commercial and organizational trajectory remains unverified. Funding, adoption, clinical validation, and product expansion milestones would be needed to identify concrete inflection points.